Concepedia

Kevin C. De Braganca

KC

23

Publications

2.3K

Citations

18

H-Index

2008

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Janssen (United States)

University of Pennsylvania

Cornell University

Tel Aviv Sourasky Medical Center

Kevin C. De Braganca is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2023

23

Publications

23

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, Han Sang Kim, Linda Bojmar et al. · Cell · 2020 · 1.2K citations · Full text

, , +5

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

Adam D. Cohen, Samir Parekh, Bianca Santomasso et al. · Blood Cancer Journal · 2022 · 235 citations · Full text

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

Adam D. Cohen, María‐Victoria Mateos, Yaël C. Cohen et al. · Blood · 2022 · 182 citations · Full text

, , +15

Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer

Kevin C. De Braganca, Yelena Y. Janjigian, Christopher G. Azzoli et al. · Journal of Neuro-Oncology · 2010 · 103 citations

, , +5

A phase II study of radioimmunotherapy with intraventricular <sup>131</sup>I‐3F8 for medulloblastoma

Kim Kramer, Neeta Pandit‐Taskar, John L. Humm et al. · Pediatric Blood & Cancer · 2017 · 64 citations

Rows per page

1–5 of 23